查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1574766

糖尿病眼科疾病設備市場：按產品類型、最終用戶、適應症、技術 - 全球預測 2025-2030

Diabetic Eye Disease Devices Market by Product Type (Diagnostic Devices, Treatment Devices), End User (Ambulatory Surgical Centers, Hospitals, Ophthalmic Clinics), Indication, Technology - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年糖尿病眼科疾病設備市場價值為173.8億美元，預計2024年將達到189.2億美元，複合年成長率為9.56%，預計到2030年將達到329.5億美元。

糖尿病眼科疾病設備覆蓋範圍包括各種旨在診斷、監測和治療糖尿病引起的眼部相關併發症的醫療設備和技術，包括糖尿病視網膜病變、糖尿病黃斑部水腫、白內障和醫療設備。這些設備對於預防糖尿病患者視力喪失和失明至關重要，並且已成為醫療保健系統的必需品。典型應用包括影像系統，例如光同調斷層掃瞄、篩檢工具、雷射治療和人工水晶體。最終用途範圍包括醫院、專業眼科診所和積極管理糖尿病患者眼睛健康的研究機構。全球糖尿病盛行率不斷上升、人們對糖尿病併發症的認知不斷提高，以及診斷影像和微創治療解決方案的技術進步，對市場成長產生了重大影響。由於糖尿病人口的快速成長和未滿足的醫療保健需求，亞太市場擴張的機會比比皆是。治療方法包括投資遠端醫療平台和人工智慧主導的診斷工具，以提高早期檢測和治療能力。然而，先進設備成本高、法規環境嚴格、農村地區的可及性有限等限制因素為市場拓展帶來了挑戰。持續的研究和開發對於探索個人化醫療方法、機器人輔助手術工具和增強的影像模式等創新至關重要，這些創新可能會徹底改變患者的治療結果並擴大市場佔有率。市場是動態的，其特徵是技術快速發展和主要參與者之間的競爭聯盟。在新興經濟體，專注於開發具有成本效益的可攜式設備和擴大分銷網路的公司將取得長足進展。此外，與非營利組織和政府衛生計畫建立合作夥伴關係可以潛在地提高可及性和市場滲透率。儘管整體前景看好，但必須謹慎應對糖尿病眼科疾病設備市場的挑戰，以充分利用糖尿病眼科疾病整體管理的新興機會。

主要市場統計
基準年[2023] 173.8億美元
預測年份 [2024] 189.2億美元
預測年份 [2030] 329.5億美元
複合年成長率（%） 9.56%

市場動態：快速發展的糖尿病眼科疾病設備市場的關鍵市場洞察

供需的動態交互作用正在改變糖尿病眼科疾病設備市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 在糖尿病眼科保健中更多地採用遠端醫療和數位健康解決方案
    • 行業主要企業之間的合作以促進創新和市場拓展
    • 增加糖尿病視網膜病變治療的研發投入
    • 透過擴大新興市場的醫療基礎設施來增加獲得治療的機會
  • 市場限制因素
    • 糖尿病眼科疾病設備的高資本成本和產品召回
  • 市場機會
    • 先進的人工智慧驅動平台，可準確診斷糖尿病眼科疾病
    • 為服務不足的糖尿病患者提供經濟實惠的攜帶式篩檢工具
    • 糖尿病視網膜病變非侵入性治療儀的開發
  • 市場挑戰
    • 缺乏熟練的專業人員和設備的技術限制

波特五力：駕馭糖尿病眼科疾病設備市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解糖尿病眼科疾病設備市場的外部影響

外部宏觀環境因素在塑造糖尿病眼科疾病設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解糖尿病眼科疾病設備市場的競爭格局

對糖尿病眼科疾病設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣糖尿病眼科疾病設備市場供應商的績效評估

FPNV 定位矩陣是評估糖尿病眼科疾病設備市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了糖尿病眼科疾病設備市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對糖尿病眼科疾病設備市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 在糖尿病眼科保健中更多地採用遠端醫療和數位健康解決方案
      • 產業主要企業之間的合作創新與拓展市場
      • 增加糖尿病視網膜病變治療研發投資
      • 擴大新興市場的醫療保健基礎設施改善獲得護理的機會
    • 抑制因素
      • 糖尿病眼科疾病設備的高資本成本和產品召回
    • 機會
      • 尖端人工智慧驅動平台，精準診斷糖尿病眼科疾病
      • 為服務不足的糖尿病患者提供負擔得起的攜帶式篩檢工具
      • 糖尿病視網膜病變非侵入性治療設備的開發
    • 任務
      • 缺乏熟練的專業人員和設備的技術限制
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章糖尿病眼科疾病設備市場：依產品類型

  • 診斷設備
    • 螢光螢光造影
    • 眼底攝影機
    • 光學同調斷層掃描(OCT) 掃描儀
  • 治療設備
    • 人工水晶體(IOL)
    • 雷射系統
      • 光凝雷射
      • 光破壞雷射
    • 玻璃體切除裝置

第7章糖尿病眼科疾病設備市場：依最終使用者分類

  • 門診手術中心
  • 醫院
  • 眼科診所

第8章糖尿病眼科疾病設備市場（依適應症）

  • 糖尿病黃斑部水腫（DME）
    • 擴散二甲醚
    • 焦點測距儀
  • 糖尿病視網膜病變
    • 非增殖性糖尿病視網膜病變
    • 增殖性糖尿病視網膜病變

第9章糖尿病眼科疾病設備市場：依技術分類

  • 玻璃體內注射
  • 雷射治療
  • 玻璃體切除手術

第10章美洲糖尿病眼科疾病設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太糖尿病眼科疾病設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲糖尿病眼科疾病設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-535C6291891B

The Diabetic Eye Disease Devices Market was valued at USD 17.38 billion in 2023, expected to reach USD 18.92 billion in 2024, and is projected to grow at a CAGR of 9.56%, to USD 32.95 billion by 2030.

The scope of diabetic eye disease devices encompasses a range of medical equipment and technologies designed to diagnose, monitor, and treat eye-related complications arising from diabetes, including diabetic retinopathy, diabetic macular edema, cataracts, and glaucoma. These devices are crucial in preventing vision impairment and blindness in diabetic patients, making them a necessity within the healthcare system. Primary applications include imaging systems like optical coherence tomography, screening tools, laser therapies, and intraocular lenses. The end-use scope covers hospitals, specialized eye clinics, and research institutes actively managing diabetic eye health. Market growth is significantly influenced by the rising prevalence of diabetes globally, increasing awareness about diabetic complications, and technological advancements in diagnostic imaging and minimally invasive treatment solutions. Opportunities abound in expanding markets in Asia-Pacific due to burgeoning diabetic populations and unmet healthcare needs. Recommendations include investing in telemedicine platforms and AI-driven diagnostic tools that can enhance early detection and treatment capabilities. However, limitations such as high costs of advanced devices, stringent regulatory environments, and limited accessibility in rural regions challenge market expansion. Continuous R&D is essential in exploring innovations like personalized medicine approaches, robotic-assisted surgical tools, and enhanced imaging modalities, which could revolutionize patient outcomes and expand market presence. The market is dynamic, characterized by rapid technological evolution and competitive collaborations among key players. Organizations focusing on developing cost-effective, portable devices and expanding distribution networks in emerging economies stand to make significant strides. Furthermore, fostering partnerships with non-profits and governmental health programs could bolster accessibility and market penetration. Overall, while promising, the diabetic eye disease devices market requires careful navigation of its challenges to fully capitalize on the burgeoning opportunities for holistic management of diabetic eye conditions.

KEY MARKET STATISTICS
Base Year [2023] USD 17.38 billion
Estimated Year [2024] USD 18.92 billion
Forecast Year [2030] USD 32.95 billion
CAGR (%) 9.56%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Diabetic Eye Disease Devices Market

The Diabetic Eye Disease Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing adoption of telemedicine and digital health solutions for diabetic eye care
    • Collaborations between key industry players to innovate and expand market reach
    • Growing investments in research and development for diabetic retinopathy treatments
    • Expansion of healthcare infrastructure in emerging markets increasing access to care
  • Market Restraints
    • High capital costs and product recalls of diabetic eye disease devices
  • Market Opportunities
    • Cutting-edge AI-driven platforms for accurate diabetic eye disease diagnostics
    • Affordable and portable screening tools for underserved diabetic populations
    • Development of non-invasive therapeutic devices for diabetic retinopathy treatment
  • Market Challenges
    • Limited availability of skilled professionals and technical limitations with devices

Porter's Five Forces: A Strategic Tool for Navigating the Diabetic Eye Disease Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Diabetic Eye Disease Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Diabetic Eye Disease Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Diabetic Eye Disease Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Diabetic Eye Disease Devices Market

A detailed market share analysis in the Diabetic Eye Disease Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Diabetic Eye Disease Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Diabetic Eye Disease Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Diabetic Eye Disease Devices Market

A strategic analysis of the Diabetic Eye Disease Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Diabetic Eye Disease Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alcon Inc., Allergan plc, Bayer AG, BD (Becton, Dickinson and Company), Carl Zeiss AG, Clearside Biomedical, Inc., F. Hoffmann-La Roche Ltd, Genentech, Inc., GlaxoSmithKline plc, Iveric Bio, Inc., Novartis AG, Ocular Therapeutix, Inc., Optos plc, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Sanofi S.A., Santen Pharmaceutical Co., Ltd., Topcon Corporation, and Vitreoretinal Technologies, Inc..

Market Segmentation & Coverage

This research report categorizes the Diabetic Eye Disease Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Diagnostic Devices and Treatment Devices. The Diagnostic Devices is further studied across Fluorescein Angiography, Fundus Cameras, and Optical Coherence Tomography (OCT) Scanners. The Treatment Devices is further studied across Intraocular Lenses (IOLs), Laser Systems, and Vitrectomy Devices. The Laser Systems is further studied across Photocoagulation Lasers and Photodisruption Lasers.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Hospitals, and Ophthalmic Clinics.
  • Based on Indication, market is studied across Diabetic Macular Edema (DME) and Diabetic Retinopathy. The Diabetic Macular Edema (DME) is further studied across Diffuse DME and Focal DME. The Diabetic Retinopathy is further studied across Non-Proliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy.
  • Based on Technology, market is studied across Intravitreal Injections, Laser Therapy, and Vitrectomy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing adoption of telemedicine and digital health solutions for diabetic eye care
      • 5.1.1.2. Collaborations between key industry players to innovate and expand market reach
      • 5.1.1.3. Growing investments in research and development for diabetic retinopathy treatments
      • 5.1.1.4. Expansion of healthcare infrastructure in emerging markets increasing access to care
    • 5.1.2. Restraints
      • 5.1.2.1. High capital costs and product recalls of diabetic eye disease devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Cutting-edge AI-driven platforms for accurate diabetic eye disease diagnostics
      • 5.1.3.2. Affordable and portable screening tools for underserved diabetic populations
      • 5.1.3.3. Development of non-invasive therapeutic devices for diabetic retinopathy treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Limited availability of skilled professionals and technical limitations with devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Diabetic Eye Disease Devices Market, by Product Type

  • 6.1. Introduction
  • 6.2. Diagnostic Devices
    • 6.2.1. Fluorescein Angiography
    • 6.2.2. Fundus Cameras
    • 6.2.3. Optical Coherence Tomography (OCT) Scanners
  • 6.3. Treatment Devices
    • 6.3.1. Intraocular Lenses (IOLs)
    • 6.3.2. Laser Systems
      • 6.3.2.1. Photocoagulation Lasers
      • 6.3.2.2. Photodisruption Lasers
    • 6.3.3. Vitrectomy Devices

7. Diabetic Eye Disease Devices Market, by End User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals
  • 7.4. Ophthalmic Clinics

8. Diabetic Eye Disease Devices Market, by Indication

  • 8.1. Introduction
  • 8.2. Diabetic Macular Edema (DME)
    • 8.2.1. Diffuse DME
    • 8.2.2. Focal DME
  • 8.3. Diabetic Retinopathy
    • 8.3.1. Non-Proliferative Diabetic Retinopathy
    • 8.3.2. Proliferative Diabetic Retinopathy

9. Diabetic Eye Disease Devices Market, by Technology

  • 9.1. Introduction
  • 9.2. Intravitreal Injections
  • 9.3. Laser Therapy
  • 9.4. Vitrectomy

10. Americas Diabetic Eye Disease Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Diabetic Eye Disease Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Diabetic Eye Disease Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Alcon Inc.
  • 3. Allergan plc
  • 4. Bayer AG
  • 5. BD (Becton, Dickinson and Company)
  • 6. Carl Zeiss AG
  • 7. Clearside Biomedical, Inc.
  • 8. F. Hoffmann-La Roche Ltd
  • 9. Genentech, Inc.
  • 10. GlaxoSmithKline plc
  • 11. Iveric Bio, Inc.
  • 12. Novartis AG
  • 13. Ocular Therapeutix, Inc.
  • 14. Optos plc
  • 15. Pfizer Inc.
  • 16. Regeneron Pharmaceuticals, Inc.
  • 17. Sanofi S.A.
  • 18. Santen Pharmaceutical Co., Ltd.
  • 19. Topcon Corporation
  • 20. Vitreoretinal Technologies, Inc.

LIST OF FIGURES

  • FIGURE 1. DIABETIC EYE DISEASE DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. DIABETIC EYE DISEASE DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DIABETIC EYE DISEASE DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DIABETIC EYE DISEASE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIABETIC EYE DISEASE DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIABETIC EYE DISEASE DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FLUORESCEIN ANGIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FUNDUS CAMERAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY (OCT) SCANNERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INTRAOCULAR LENSES (IOLS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PHOTOCOAGULATION LASERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PHOTODISRUPTION LASERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY VITRECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIFFUSE DME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FOCAL DME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY NON-PROLIFERATIVE DIABETIC RETINOPATHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PROLIFERATIVE DIABETIC RETINOPATHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INTRAVITREAL INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY VITRECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 73. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 120. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 129. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 142. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 151. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 152. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 160. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 169. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 170. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 178. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 187. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 188. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 189. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 196. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 197. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 198. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 205. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 206. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 207. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 222. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 224. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 225. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 226. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 231. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 233. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 234. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 235. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 242. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 243. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 244. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 245. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 249. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 251. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 252. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 253. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 254. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 258. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 260. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 261. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 262. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 263. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 269. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 270. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 271. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 272. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 273. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 274. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 276. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 278. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 279. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 280. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 281. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 282. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 283. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 285. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 287. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 288. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 289. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 290. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 291. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 292. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 293. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 294. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 296. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 297. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 298. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 299. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 300. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 301. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 302. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 303. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 304. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 305. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 306. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 307. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 308. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)

TABLE